High resolution solution structure of a DNA duplex alkylated by the antitumor agent duocarmycin SA.
暂无分享,去创建一个
D. Case | D. Boger | W. Chazin | P. S. Eis | J. A. Smith | J. Rydzewski | Peggy S. Eis | Jarrod A. Smith | Jan M. Rydzewski | David A. Case | Dale L. Boger | P. S. Eis
[1] D. Boger,et al. Catalysis of the CC-1065 and duocarmycin DNA alkylation reaction: DNA binding induced conformational change in the agent results in activation. , 1997, Bioorganic & medicinal chemistry.
[2] D. Case,et al. Molecular Dynamics Docking Driven by NMR‐Derived Restraints to Determine the Structure of the Calicheamicin γ1I Oligosaccharide Domain Complexed to Duplex DNA , 1996 .
[3] D. Boger,et al. Examination of the role of the duocarmycin SA methoxy substituents: Identification of the minimum, fully potent DNA binding subunit , 1996 .
[4] D. Boger,et al. A comparative study of the solvolysis reactivity, regioselectivity, and stereochemistry of the duocarmycin a and sa alkylation subunits , 1996 .
[5] D. Boger,et al. CC-1065 AND THE DUOCARMYCINS : UNDERSTANDING THEIR BIOLOGICAL FUNCTION THROUGH MECHANISTIC STUDIES , 1996 .
[6] D E Wemmer,et al. Interproton distance bounds from 2D NOE intensities: Effect of experimental noise and peak integration errors , 1995, Journal of biomolecular NMR.
[7] Jean-Claude Spehner,et al. Fast and robust computation of molecular surfaces , 1995, SCG '95.
[8] D. Boger. The Duocarmycins: Synthetic and Mechanistic Studies , 1995 .
[9] D. Patel,et al. Solution structure of the covalent duocarmycin A-DNA duplex complex. , 1995, Journal of molecular biology.
[10] W. Chazin,et al. Determination of the solution structure of Apo calbindin D9k by NMR spectroscopy. , 1995, Journal of molecular biology.
[11] D. Boger,et al. (+)- and ent-(-)-Duocarmycin SA and (+)- and ent-(-)-N-BOC-DSA DNA Alkylation Properties.Alkylation Site Models That Accommodate the Offset AT-Rich Adenine N3 Alkylation Selectivity of the Enantiomeric Agents , 1994 .
[12] D. Boger,et al. Reversibility of the duocarmycin A and SA DNA alkylation reaction , 1993 .
[13] D. Patel,et al. Site-specific covalent duocarmycin A-intramolecular DNA triplex complex , 1992 .
[14] T. James,et al. Solution structure of a DNA octamer containing the Pribnow box via restrained molecular dynamics simulation with distance and torsion angle constraints derived from two-dimensional nuclear magnetic resonance spectral fitting. , 1992, Journal of molecular biology.
[15] B. Reid,et al. Determination of nucleic acid backbone conformation by proton nmr , 1992 .
[16] W. Chazin,et al. Comparative NMR analysis of the decadeoxynucleotide d-(GCATTAATGC)2 and an analogue containing 2-aminoadenine. , 1991, Nucleic Acids Research.
[17] D. Patel,et al. Heteronuclear two‐dimensional 15N‐ and 13C‐nmr studies of DNA oligomers and their netropsin complexes using indirect proton detection , 1991, Biopolymers.
[18] D. Boger,et al. Duocarmycin-pyrindamycin DNA alkylation properties and identification, synthesis, and evaluation of agents incorporating the pharmacophore of the duocarmycin-pyrindamycin alkylation subunit. Identification of the CC-1065 duocarmycin common pharmacophore , 1990 .
[19] C. H. Lin,et al. Determination of the major tautomeric form of the covalently modified adenine in the (+)-CC-1065-DNA adduct by 1H and 15N NMR studies. , 1990, Biochemistry.
[20] B. Borgias,et al. MARDIGRAS : a procedure for matrix analysis of relaxation for discerning geometry of an aqueous structure , 1990 .
[21] T. Scahill,et al. An NMR study of the covalent and noncovalent interactions of CC-1065 and DNA. , 1990, Biochemistry.
[22] R. S. Coleman,et al. Natural and Synthetic Antitumor Agents: Synthetic Studies on CC-1065 and Functionally Related Agents , 1990 .
[23] R. S. Coleman,et al. A demonstration of the intrinsic importance of stabilizing hydrophobic binding and non-covalent van der Waals contacts dominant in the non-covalent CC-1065/B-DNA binding. , 1990, Chemico-biological interactions.
[24] P. Dervan,et al. Sequence-specific cleavage of DNA by N-bromoacetyldistamycin. Product and kinetic analyses , 1989 .
[25] D. G. Davis. Elimination of baseline distortions and minimization of artifacts from phased 2D NMR spectra , 1989 .
[26] B. Borgias,et al. Two-dimensional nuclear Overhauser effect: complete relaxation matrix analysis. , 1989, Methods in enzymology.
[27] A. Bax,et al. P.COSY, a sensitive alternative for double-quantum-filtered COSY , 1988 .
[28] C. W. Hilbers,et al. Nucleic acids and nuclear magnetic resonance. , 1988, European journal of biochemistry.
[29] M. Warpehoski,et al. Sequence selectivity of DNA covalent modification. , 1988, Chemical research in toxicology.
[30] A. J. Shaka,et al. Iterative schemes for bilinear operators; application to spin decoupling , 1988 .
[31] Atta-ur- Rahman,et al. Studies in natural products chemistry , 1988 .
[32] M. Rance. Improved techniques for homonuclear rotating-frame and isotropic mixing experiments , 1987 .
[33] B. Reid. Sequence-specific assignments and their use in NMR studies of DNA structure , 1987, Quarterly Reviews of Biophysics.
[34] D. Patel,et al. DNA and RNA: NMR studies of conformations and dynamics in solution , 1987, Quarterly Reviews of Biophysics.
[35] G. A. van der Marel,et al. An NMR study of the polymorphous behavior of the mismatched DNA octamer d(m5C-G-m5C-G-T-G-m5C-G) in solution. The B, Z, and hairpin forms. , 1987, Journal of biomolecular structure & dynamics.
[36] L. Mueller. P.E.COSY, a simple alternative to E.COSY , 1987 .
[37] G. Wagner,et al. Assignment of the 13C nuclear magnetic resonance spectrum of a short DNA-duplex with 1H-detected two-dimensional heteronuclear correlation spectroscopy , 1987, Nucleic Acids Res..
[38] W. Saenger,et al. DNA-ligand interactions : from drugs to proteins , 1987 .
[39] B. Lambert,et al. Pharmacology of DNA Binding Drugs , 1987 .
[40] D. Patel,et al. Nuclear magnetic resonance and distance geometry studies of DNA structures in solution. , 1987, Annual review of biophysics and biophysical chemistry.
[41] K. Wüthrich. NMR of proteins and nucleic acids , 1988 .
[42] K. Wüthrich,et al. 1H nuclear magnetic resonance assignments for d-(GCATTAATGC)2 using experimental refinements of established procedures. , 1986, Journal of molecular biology.
[43] L. Hurley,et al. Covalent Binding of Antitumor Antibiotics in the Minor Groove of DNA. Mechanism of Action of CC-1065 and the Pyrrolo (1,4) benzodiazepines , 1986 .
[44] L. Hurley,et al. The chemistry, mechanism of action and biological properties of CC-1065, a potent antitumor antibiotic. , 1986, The Journal of antibiotics.
[45] C Zimmer,et al. Nonintercalating DNA-binding ligands: specificity of the interaction and their use as tools in biophysical, biochemical and biological investigations of the genetic material. , 1986, Progress in biophysics and molecular biology.
[46] Ad Bax,et al. MLEV-17-based two-dimensional homonuclear magnetization transfer spectroscopy , 1985 .
[47] B. Reid,et al. High Resolution NMR Studies of Nucleic Acids and Proteins , 1985 .
[48] L. Hurley,et al. Reaction of the antitumor antibiotic CC-1065 with DNA: structure of a DNA adduct with DNA sequence specificity. , 1984, Science.
[49] Richard R. Ernst,et al. Coherence transfer by isotropic mixing: Application to proton correlation spectroscopy , 1983 .
[50] K. Wüthrich,et al. Application of phase sensitive two-dimensional correlated spectroscopy (COSY) for measurements of 1H-1H spin-spin coupling constants in proteins. , 1983, Biochemical and biophysical research communications.
[51] M. Rance,et al. Obtaining high-fidelity spin-12 powder spectra in anisotropic media: Phase-cycled Hahn echo spectroscopy , 1983 .
[52] G. Bodenhausen,et al. Analysis of networks of coupled spins by multiple quantum N.M.R. , 1983 .
[53] Pierre Plateau,et al. Exchangeable proton NMR without base-line distorsion, using new strong-pulse sequences , 1982 .
[54] C. Altona,et al. Thermodynamics of Stacking and of Self‐Association of the Dinucleoside Monophosphate m62A‐U from Proton NMR Chemical Shifts: , 1982 .
[55] D. V. Von Hoff,et al. CC-1065 (NSC 298223), a most potent antitumor agent: kinetics of inhibition of growth, DNA synthesis, and cell survival. , 1982, Cancer research.
[56] W. C. Krueger,et al. CC-1065 (NSC 298223), a potent new antitumor agent improved production and isolation, characterization and antitumor activity. , 1981, The Journal of antibiotics.
[57] Richard R. Ernst,et al. Elucidation of cross relaxation in liquids by two-dimensional N.M.R. spectroscopy , 1980 .